Skip to main content
Depletion Comparison · Based on CTD Molecular Database

Prednisone vs Dexamethasone: Nutrient Depletion Comparison

Prednisone and dexamethasone both deplete seven nutrients — calcium, vitamin D, potassium, magnesium, zinc, vitamin C, and chromium — through glucocorticoid receptor activation. Dexamethasone is 6–7x more potent with no mineralocorticoid activity, while prednisone is a prodrug requiring liver conversion. Both devastate bone mineral density, drive insulin resistance, and suppress immune function — making corticosteroids the most nutrient-depleting drug class per dose.

Compare YOUR medications' depletionsFree, 10 seconds →

Data sourced from CTD, ChEMBL, FAERS. How we verify this data →
Sources verified as of April 2026
[01]

At a Glance

Drug A
Prednisone
7 depletions

Prednisone is a prodrug converted to prednisolone in the liver, then activates glucocorticoid receptors that reduce intestinal calcium absorption by 30–50%, accelerate vitamin D metabolism through CYP3A4 induction, increase renal potassium and magnesium excretion, deplete zinc through catabolic protein breakdown, consume vitamin C as an antioxidant against corticosteroid-induced oxidative stress, and impair chromium-mediated insulin signaling. The mineralocorticoid activity (present at moderate potency) further drives sodium retention and potassium wasting.

Prednisone reaches 80% bioavailability with a 2-hour plasma half-life, but biological half-life extends to 18–36 hours, meaning metabolic and nutrient-depleting effects persist long after the drug clears the blood.

Pros
  • Moderate potency allows flexible dose titration from physiologic (5 mg) to pharmacologic (60+ mg) doses
  • Mineralocorticoid activity provides some sodium retention — useful in adrenal insufficiency replacement
  • Shorter biological half-life (18–36h) allows alternate-day dosing that partially spares the HPA axis
  • Decades of clinical experience with well-established tapering protocols
Cons
  • Seven-nutrient depletion burden — the broadest of any common medication class
  • Calcium and vitamin D depletion drives osteoporosis — fracture risk doubles within first 3 months
  • Requires liver conversion to prednisolone — impaired in hepatic dysfunction
  • Insulin resistance from chromium depletion and direct glucocorticoid effects creates steroid diabetes
Best For

Short-to-moderate corticosteroid courses for inflammatory conditions, adrenal insufficiency replacement therapy, and situations where alternate-day dosing can minimize depletion.

Drug B
Dexamethasone
7 depletions

Dexamethasone is 6–7x more potent than prednisone with zero mineralocorticoid activity — pure glucocorticoid effect. It directly activates glucocorticoid receptors without requiring liver conversion, creating the same seven-nutrient depletion cascade but at dramatically higher intensity per milligram. The absence of mineralocorticoid activity means less sodium retention but equally aggressive potassium wasting, calcium malabsorption, vitamin D catabolism, and chromium-mediated insulin disruption.

Dexamethasone has 74% bioavailability with a 4-hour plasma half-life, but its biological half-life extends to 36–72 hours — the longest of any common corticosteroid, meaning a single dose sustains metabolic disruption for up to 3 days.

Pros
  • No liver activation required — works immediately and predictably in hepatic impairment
  • Zero mineralocorticoid activity avoids sodium retention and edema
  • Long 36–72 hour biological half-life means less frequent dosing for sustained anti-inflammatory coverage
  • COVID-19 RECOVERY trial proved mortality benefit in severe respiratory illness
Cons
  • 6–7x more potent than prednisone — each milligram depletes nutrients far more aggressively
  • 36–72 hour biological half-life means depletion effects persist for days after each dose
  • Cannot be dosed on alternate days effectively — too long-acting to spare HPA axis
  • More potent HPA axis suppression makes withdrawal and adrenal recovery more difficult
Best For

Acute inflammatory crises, cerebral edema, severe COVID-19, cancer chemotherapy protocols, and situations requiring maximum anti-inflammatory potency without mineralocorticoid effects.

[02]

Feature Comparison

FeaturePrednisoneDexamethasone
Drug ClassGlucocorticoid (intermediate potency, prodrug)Glucocorticoid (high potency, direct)
Nutrients Depleted7 — Ca, vitamin D, K, Mg, Zn, vitamin C, Cr7 — Ca, vitamin D, K, Mg, Zn, vitamin C, Cr
Relative Potency1x (reference)6–7x more potent
Biological Half-Life18–36 hours36–72 hours
Mineralocorticoid ActivityModerate (sodium retention)None
Hepatic ActivationRequired (prodrug)Not required (direct)
Alternate-Day DosingPossible (HPA-sparing)Not feasible (too long-acting)
Dose Equivalence5 mg prednisone0.75 mg dexamethasone

Wondering which medication depletes less?

Check your medications free — 10 seconds →
[03]

Verdict

Both corticosteroids deplete the same seven nutrients — the most of any common drug class — through identical glucocorticoid receptor activation. The differences are potency and duration. Dexamethasone's 6–7x potency means each milligram hits harder, and its 36–72 hour biological half-life means depletion persists for days per dose — no alternate-day scheduling can spare the HPA axis or reduce cumulative nutrient impact. Prednisone's moderate potency and 18–36 hour biological half-life allow alternate-day dosing that partially preserves adrenal function and creates intermittent nutrient recovery windows. For acute crises needing maximum anti-inflammatory power (cerebral edema, severe COVID, chemotherapy), dexamethasone's potency justifies the deeper depletion. For chronic inflammatory conditions requiring ongoing therapy, prednisone's flexibility with alternate-day scheduling offers genuine nutrient preservation advantages. Either way, calcium, vitamin D, and potassium supplementation are mandatory from the first dose.

[04]

FAQ

[05]

References

  1. [1]CTD (Comparative Toxicogenomics Database): gene interactions for both drugs affecting glucocorticoid receptor, calcium transport, and insulin signaling pathways
  2. [2]RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with COVID-19. N Engl J Med. 2021;384(8):693-704
  3. [3]FAERS (FDA Adverse Event Reporting System): safety reports for both prednisone and dexamethasone across inflammatory and oncologic indications
  4. [4]PubMed PMID 12421743 — Van Staa TP et al. Use of oral corticosteroids and risk of fractures. J Bone Miner Res. 2000;15(6):993-1000
  5. [5]PubMed PMID 21870526 — Saag KG et al. American College of Rheumatology 2017 guideline for glucocorticoid-induced osteoporosis prevention and treatment
This information is generated from peer-reviewed molecular databases including the Comparative Toxicogenomics Database (CTD), ChEMBL, and indexed PubMed research. It is not medical advice. Always consult your healthcare provider before making changes to your medications or supplements. See our methodology →

Compare All Your Medications

Free. No signup. 10 seconds.

Check Now →